Congress Killed Its Own Stock-Trading Ban — Here's Why
GOP lawmakers torpedoed legislation that would have barred congressional stock trading. The reasons are damning either way.
Congressional stock trading is one of those issues where the public outrage is deafening and bipartisan. Polls consistently show voters on both sides want lawmakers banned from picking individual stocks while writing laws that move markets. So when Republicans actively undermined their own bill designed to do exactly that, it raised an obvious question: why would you kill something you publicly supported?
MarketWatch flags two possible explanations — and neither one flatters the people involved. The first is pure self-interest. Members of Congress trade stocks at rates and returns that raise serious eyebrows, and a ban would hit their portfolios directly. Voting to kill the bill while pretending to champion it is a classic Washington two-step: take the populist credit, avoid the personal cost.
Read more US Waives Human Rights Terms on Egypt Military Aid Over Iran →
The second explanation is arguably worse: institutional protection. Congress as a body has a financial information advantage over ordinary investors. Lawmakers sit in classified briefings, mark up legislation before it's public, and talk to regulators behind closed doors. That edge is worth something — and some members may want to keep that arrangement intact for the institution, not just themselves.
For retail traders, this matters in a concrete way. As long as congressional trading goes unchecked, you are competing against people with structural information advantages you will never have. Following congressional trade disclosures — which are public under existing law — remains one of the few tools available to level that playing field. Services that track these filings exist, and some retail traders use them actively.
The collapse of this reform effort signals that meaningful restrictions on congressional trading are not coming soon. Don't wait for Washington to fix this one. Continue reading at MarketWatch.com